ION Breast Cancer Clinical Pathways - ION Solutions
ION Breast Cancer Clinical Pathways - ION Solutions
ION Breast Cancer Clinical Pathways - ION Solutions
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Camptosar (Irinotecan) Avastin (Bevacizumab) EP=Moderate; FN> TherAdvMedOncol2010Sep;2(5):309-17Camptosar (Irinotecan) Vectibix (Panitumumab) EP=Moderate; FN> NEnglJMed2004;351:337-345FOLFIRI Vectibix (Panitumumab) EP=Moderate; FN=10%-20%Irinotecan 180mg/m2 D1, D15Leucovorin 400mg/m2 D1, D155-Fluorouracil 400mg/m2 IVP D1, D155-Fluorouracil 2400mg/m2 CI over 46 hours D1, D15Panitumumab 6mg/kg D1, D15q 28 Day Cycle>> BrJ<strong>Cancer</strong>2008Aug5;99(3):455-8Erbitux (Cetuximab) EP=Minimal; FN> NEnglJMed2004;351:337-345Xeloda (Capecitabine) +/- Erbitux (Cetuximab) EP=Low; FN> JClinOncol2005Feb1;23(4):792-9>> J Clin Oncol 19:4097-4106, 2001>> J Clin Oncol 26:2013-2019, 2008FOLFIRI Zaltrap (Ziv-aflibercept) EP=Moderate; FN=10%-20%Irinotecan 180mg/m 2 D1, D15Leucovorin 400mg/m 2 D1, D155-Fluorouracil 400mg/m 2 IVP D1, D155-Fluorouracil 2400mg/m 2 CI over 46 hours D1, D15Ziv-aflibercept 4mg/kg D1, D15q 28 Day Cycle>> J Clin Oncol 30 (suppl):3505, 2012<strong>Clinical</strong> Trial:Screen patient for clinical trial. Check www.clinicaltrials.gov for available trials.Best Supportive Care and/or Hospice:Consider supportive care options and Hospice when appropriate.Page 19 of 39© 2013 by <strong>ION</strong> <strong>Solutions</strong>. All rights reserved
Change language